Mid-Market: S&P/ASX 200 Trading Higher By 0.39%; Lifted By Information Technology

On 12 December 2023, at AEDT 11:38 AM, the benchmark index S&P/ASX 200 is trading higher today, gaining 27.90 points or 0.39%, and is currently trading at 7,226.90 levels. Out of 11 sectors, 07 sectors are trading higher along with the S&P/ASX 200.

The Information Technology and Healthcare sectors are the top 2 gaining sectors, gaining 0.75% and 0.63% in their index values. On the other hand, the Energy and Utilities sectors are the top 2 losing sectors, declining 0.40% and 0.36% in their index values.

Costa Group Holdings Limited (ASX: CGC) and Telix Pharmacy Limited (ASX: TLX) are the top-gaining stocks, gaining 2.702% and 2.092% in their stock prices. On the other hand, Chalice Mining Limited (ASX: CHN) and Lynas Rare Earth Limited (ASX: LYC) are the top-losing stocks and are declining by 3.231% and 3.086% in their stock prices.

Factors influencing the market-

• Sigma Healthcare will exit a trading halt following the announcement of an $8.8 billion merger with Chemist Warehouse.
• Incitec Pivot's shares rose 0.5% to $2.87 as Mauro Neves de Moraes was appointed CEO, set to assume the role from January 22.
• Reserve Bank governor Michele Bullock, addressing Sydney, expressed confidence that Australia is effectively managing inflation.
• Oil stabilized after concerns of oversupply triggering the longest weekly losing streak in five years.
• Dow closed up by 0.43%, S&P 500 by 0.39%, and NASDAQ higher by 0.20%.
• Hang Seng is down by -0.81%, and FTSE 100 is down by -0.13% today.

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com